Simrat Randhawa

Insider Reports History

Location
New York, NY
Signature
/s/ Adam Veness, as attorney-in-fact for Simrat Randhawa
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simrat Randhawa:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dianthus Therapeutics, Inc. /DE/ EVP, Head of R&D Common Stock 4,000 $152,560 $38.14 14 Nov 2025 Direct
Dianthus Therapeutics, Inc. /DE/ EVP, Head of R&D Stock Option (Right to Buy) 150,000 03 Feb 2026 Direct

Insider Reports Filed by Simrat Randhawa

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DNTH Dianthus Therapeutics, Inc. /DE/ 03 Feb 2026 1 $0 4 EVP, Head of R&D 04 Feb 2026, 17:40
DNTH Dianthus Therapeutics, Inc. /DE/ 13 Nov 2025 14 -$4,381,751 4 EVP, Head of R&D 14 Nov 2025, 21:00
DNTH Dianthus Therapeutics, Inc. /DE/ 23 Sep 2025 1 $0 4 CHIEF MEDICAL OFFICER 25 Sep 2025, 20:01
DNTH Dianthus Therapeutics, Inc. /DE/ 03 Feb 2025 1 $0 4 CHIEF MEDICAL OFFICER 04 Feb 2025, 16:21
DNTH Dianthus Therapeutics, Inc. /DE/ 23 May 2024 1 $0 4 CHIEF MEDICAL OFFICER 28 May 2024, 20:04
DNTH Dianthus Therapeutics, Inc. /DE/ 24 Jan 2024 1 $0 4 CHIEF MEDICAL OFFICER 26 Jan 2024, 16:43
DNTH Dianthus Therapeutics, Inc. /DE/ 21 Sep 2023 2 +$52,800 4 Chief Medical Officer 25 Sep 2023, 16:15
DNTH Dianthus Therapeutics, Inc. /DE/ 11 Sep 2023 0 $0 3 Chief Medical Officer 13 Sep 2023, 20:50